SG11201504241QA - Method for evaluation of presence of or risk of colon tumors - Google Patents
Method for evaluation of presence of or risk of colon tumorsInfo
- Publication number
- SG11201504241QA SG11201504241QA SG11201504241QA SG11201504241QA SG11201504241QA SG 11201504241Q A SG11201504241Q A SG 11201504241QA SG 11201504241Q A SG11201504241Q A SG 11201504241QA SG 11201504241Q A SG11201504241Q A SG 11201504241QA SG 11201504241Q A SG11201504241Q A SG 11201504241QA
- Authority
- SG
- Singapore
- Prior art keywords
- evaluation
- risk
- colon tumors
- colon
- tumors
- Prior art date
Links
- 208000029742 colonic neoplasm Diseases 0.000 title 1
- 238000011156 evaluation Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
- G01N2800/7023—(Hyper)proliferation
- G01N2800/7028—Cancer
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Data Mining & Analysis (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Software Systems (AREA)
- Databases & Information Systems (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Artificial Intelligence (AREA)
- Evolutionary Computation (AREA)
- Epidemiology (AREA)
- Bioethics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261732024P | 2012-11-30 | 2012-11-30 | |
| US201361772979P | 2013-03-05 | 2013-03-05 | |
| PCT/US2013/072691 WO2014085826A2 (en) | 2012-11-30 | 2013-12-02 | Method for evaluation of presence of or risk of colon tumors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201504241QA true SG11201504241QA (en) | 2015-06-29 |
Family
ID=50828610
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201504241QA SG11201504241QA (en) | 2012-11-30 | 2013-12-02 | Method for evaluation of presence of or risk of colon tumors |
Country Status (11)
| Country | Link |
|---|---|
| US (6) | US20140234854A1 (en) |
| EP (1) | EP2926138A4 (en) |
| JP (1) | JP2016507723A (en) |
| KR (1) | KR20150090240A (en) |
| CN (2) | CN110596385A (en) |
| AU (1) | AU2013351947A1 (en) |
| BR (1) | BR112015012616A2 (en) |
| CA (1) | CA2893158A1 (en) |
| MX (1) | MX2015006757A (en) |
| SG (1) | SG11201504241QA (en) |
| WO (1) | WO2014085826A2 (en) |
Families Citing this family (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9141756B1 (en) | 2010-07-20 | 2015-09-22 | University Of Southern California | Multi-scale complex systems transdisciplinary analysis of response to therapy |
| CA3133249C (en) | 2012-02-09 | 2023-07-25 | Memed Diagnostics Ltd. | Signatures and determinants for diagnosing infections and methods of use thereof |
| WO2015149030A1 (en) * | 2014-03-28 | 2015-10-01 | Applied Proteomics, Inc. | Protein biomarker profiles for detecting colorectal tumors |
| AU2015287554A1 (en) * | 2014-07-11 | 2017-01-12 | Expression Pathology, Inc. | SRM/MRM assay for the GTPase KRas protein (KRas) |
| AU2015302870B2 (en) | 2014-08-14 | 2021-12-23 | Memed Diagnostics Ltd. | Computational analysis of biological data using manifold and a hyperplane |
| WO2016037134A1 (en) * | 2014-09-05 | 2016-03-10 | Nantomics, Llc | Systems and methods for determination of provenance |
| US11513123B2 (en) * | 2014-12-11 | 2022-11-29 | Wisconsin Alumni Research Foundation | Methods for detection and treatment of colorectal cancer |
| CN105807062A (en) * | 2014-12-28 | 2016-07-27 | 复旦大学 | Application of human colorectal carcinoma protein Spondin-2 to preparation of colorectal carcinoma diagnosis preparation |
| CN105385752A (en) * | 2015-03-23 | 2016-03-09 | 复旦大学 | Detection method of human colon cancer protein marker Spondin-2 and detection kit thereof |
| JP2018517892A (en) * | 2015-04-10 | 2018-07-05 | アプライド プロテオミクス，インク． | Protein biomarker panel to detect colorectal cancer and advanced adenoma |
| JP6742034B2 (en) * | 2015-11-05 | 2020-08-19 | ヴァンダービルト ユニバーシティー | Quantification of proteins in multicellular tissue samples |
| WO2017149548A1 (en) | 2016-03-03 | 2017-09-08 | Memed Diagnostics Ltd. | Rna determinants for distinguishing between bacterial and viral infections |
| CN109416926A (en) * | 2016-04-11 | 2019-03-01 | 迪森德克斯公司 | MASS SPECTRAL DATA ANALYSIS workflow |
| JP6754116B2 (en) * | 2016-04-26 | 2020-09-09 | 学校法人近畿大学 | Colorectal cancer marker |
| CN107345236A (en) * | 2016-05-04 | 2017-11-14 | 北京美泽福临科技发展有限公司 | The specificity amplification primer and diagnosis for liver cancer kit of a kind of AMY2B mRNAs |
| CA3025004A1 (en) * | 2016-06-10 | 2017-12-14 | Wisconsin Alumni Research Foundation | Methods for detection, staging, and surveillance of colorectal adenomas and carcinomas |
| EP4184167A1 (en) | 2016-07-10 | 2023-05-24 | MeMed Diagnostics Ltd. | Early diagnosis of infections |
| CN109661578B (en) | 2016-07-10 | 2022-05-10 | 米密德诊断学有限公司 | Protein signatures used to differentiate bacterial and viral infections |
| CN106202984B (en) * | 2016-08-26 | 2018-09-04 | 赵毅 | It is a kind of based on multilayer complex network to the screening technique of tumour miRNA marker |
| EP3519834A4 (en) * | 2016-09-29 | 2020-06-17 | MeMed Diagnostics Ltd. | Methods of risk assessment and disease classification |
| WO2018060998A1 (en) | 2016-09-29 | 2018-04-05 | Memed Diagnostics Ltd. | Methods of prognosis and treatment |
| US20180100858A1 (en) * | 2016-10-07 | 2018-04-12 | Applied Proteomics, Inc. | Protein biomarker panels for detecting colorectal cancer and advanced adenoma |
| EP3572805A4 (en) | 2017-01-19 | 2020-09-16 | Shimadzu Corporation | Analysis data analytics method and analysis data analytics device |
| US11204355B2 (en) | 2017-02-20 | 2021-12-21 | Vanderbilt University | Immune checkpoint molecular fitness profiling by mass spectrometry |
| CN106919801B (en) * | 2017-03-08 | 2023-07-18 | 杭州大伽信息科技有限公司 | Immunohistochemical staining auxiliary analysis system and use method |
| CN106908608B (en) * | 2017-04-17 | 2018-10-02 | 首都医科大学附属北京胸科医院 | The protein marker of auxiliary diagnosis severe secondary tuberculosis of lung |
| US20180330059A1 (en) | 2017-05-09 | 2018-11-15 | James Stewart Bates | Patient treatment systems and methods |
| US10455457B2 (en) | 2017-05-24 | 2019-10-22 | Qualcomm Incorporated | NR-SS unified operation mode in coordinated and uncoordinated bands |
| US11164679B2 (en) | 2017-06-20 | 2021-11-02 | Advinow, Inc. | Systems and methods for intelligent patient interface exam station |
| CA3068688A1 (en) * | 2017-06-30 | 2019-01-03 | National Institutes Of Biomedical Innovation, Health And Nutrition | Biomarker for detecting colorectal cancer |
| AU2018301704A1 (en) * | 2017-07-14 | 2020-03-05 | Cofactor Genomics, Inc. | Immuno-oncology applications using next generation sequencing |
| CN109406785A (en) * | 2017-08-18 | 2019-03-01 | 山东泽济生物科技有限公司 | Tumor blood markers and their applications |
| CN111684282A (en) * | 2017-12-05 | 2020-09-18 | 迪森德克斯公司 | Robust panel of colorectal cancer biomarkers |
| BR112020010430A2 (en) * | 2017-12-29 | 2020-11-24 | Abbott Laboratories | biomarkers and innovative methods to diagnose and evaluate traumatic brain injury |
| SG11202006974WA (en) * | 2018-01-22 | 2020-08-28 | Liquid Biopsy Res Llc | Methods for colon cancer detection and treatment monitoring |
| US11348688B2 (en) | 2018-03-06 | 2022-05-31 | Advinow, Inc. | Systems and methods for audio medical instrument patient measurements |
| CA3095056A1 (en) | 2018-04-13 | 2019-10-17 | Freenome Holdings, Inc. | Machine learning implementation for multi-analyte assay of biological samples |
| KR102745118B1 (en) * | 2018-07-05 | 2024-12-23 | 이디피 바이오테크 코퍼레이션 | Kits and methods for marker detection |
| CN112888793A (en) * | 2018-08-08 | 2021-06-01 | 里珍纳龙药品有限公司 | Quantification of protein biomarkers using LC-MS/MS |
| EP3623813A1 (en) * | 2018-09-17 | 2020-03-18 | Institut d'Investigació Sanitària Pere Virgili | Methods for the prognosis of hiv-infected subjects |
| EP3935394A1 (en) * | 2019-03-06 | 2022-01-12 | Diadem S.r.l. | P53 peptides as markers in the diagnosis and prognosis of alzheimer's disease |
| WO2021097302A1 (en) * | 2019-11-13 | 2021-05-20 | University Of South Florida | Systems and methods of deep learning for colorectal polyp screening |
| CN110951707B (en) * | 2019-12-31 | 2022-11-11 | 南京医科大学 | Pyruvate kinase M2 mutants and their application in cardiovascular disease |
| CN115616230A (en) * | 2020-03-18 | 2023-01-17 | 龙海市第一医院 | ELISA kit for detection of fucosylated apolipoprotein H for early diagnosis of liver cancer |
| WO2022006628A1 (en) * | 2020-07-08 | 2022-01-13 | Southern Adelaide Local Health Network Inc. | Computer-implemented method and system for identifying measurable features for use in a predictive model |
| CN112194719A (en) * | 2020-09-01 | 2021-01-08 | 中日友好医院(中日友好临床医学研究所) | Preparation and application of CRT antigen and MAGE-A1 antigen |
| CN112034182A (en) * | 2020-09-01 | 2020-12-04 | 复旦大学附属中山医院 | Method and system for predicting colon cancer metastasis |
| CN112266961B (en) * | 2020-10-29 | 2023-05-12 | 中山大学附属第六医院 | Application of TSG-6 gene in predicting metastasis and prognosis of colorectal cancer |
| CN112710856B (en) * | 2020-12-16 | 2022-12-02 | 江西省肿瘤医院(江西省癌症中心) | Application of preparation for detecting serum IGF1 protein in preparation of colorectal cancer curative effect monitoring reagent |
| CN113447658B (en) * | 2021-07-01 | 2022-04-19 | 浙江大学 | Kit for detecting anti-peroxiredoxin-1-IgG antibody |
| CN113956327B (en) * | 2021-10-11 | 2024-01-30 | 中山大学肿瘤防治中心 | Polypeptide targeting human APC protein and application thereof in preparation of medicines |
| WO2023183481A1 (en) * | 2022-03-23 | 2023-09-28 | Serum Detect, Inc. | Biomarker signatures indicative of early stages of cancer |
| CN114445406B (en) * | 2022-04-07 | 2022-08-09 | 武汉大学 | Enteroscopy image analysis method and device and medical image processing equipment |
| TWI796228B (en) | 2022-05-25 | 2023-03-11 | 臺中榮民總醫院 | Acute kidney injury predicting system and method thereof |
| CN114668836B (en) * | 2022-05-27 | 2022-08-19 | 暨南大学 | Application of PDIA6 in the preparation of drugs for spinal cord injury and repair |
| CN114958794B (en) * | 2022-06-14 | 2023-06-02 | 南京工业大学 | Phenylethanolamine-N-methyltransferase hPENMT 54 and clone expression and application thereof |
| WO2024232926A1 (en) * | 2023-05-08 | 2024-11-14 | Venn Biosciences Corporation | Diagnosis of colorectal cancer using targeted quantification of peptides |
| WO2025058445A1 (en) * | 2023-09-15 | 2025-03-20 | 연세대학교 산학협력단 | Method for providing information about colorectal cancer |
| CN118067993B (en) * | 2024-04-17 | 2024-07-05 | 弗雷米德生物医药技术（天津）有限公司 | A combined detection kit for intestinal polyp detection and its preparation method, detection method and application |
| CN118496322A (en) * | 2024-05-09 | 2024-08-16 | 昆明医科大学 | Polypeptide inhibitor for targeted degradation of beta-catenin and application thereof |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4444879A (en) * | 1981-01-29 | 1984-04-24 | Science Research Center, Inc. | Immunoassay with article having support film and immunological counterpart of analyte |
| US4517289A (en) * | 1982-08-18 | 1985-05-14 | Brigham And Women's Hospital | Monoclonal antibodies for human tissue cross-matching |
| US5736343A (en) * | 1995-08-18 | 1998-04-07 | Landry; Donald | Detection of organic compounds through regulation of antibody-catalyzed reactions |
| US5800347A (en) * | 1995-11-03 | 1998-09-01 | The General Hospital Corporation | ROC method for early detection of disease |
| NO954667D0 (en) * | 1995-11-17 | 1995-11-17 | Dagfinn Oegreid | Method for detecting Ki-ras mutations |
| AU767833B2 (en) * | 1999-01-10 | 2003-11-27 | Exact Sciences Corporation | Methods of detecting colorectal disease |
| US20010041365A1 (en) * | 2000-01-10 | 2001-11-15 | Michael Laposata | Methods for monitoring alcohol consumption |
| US20040018973A1 (en) * | 2002-01-25 | 2004-01-29 | University Of Pittsburgh | Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof |
| US20050153382A1 (en) * | 2002-06-06 | 2005-07-14 | Chengdu Kuachang Science And Technology Co., Ltd. | Biochip kit comprising biochip based on antigen-antibody reactions, and its usage |
| WO2005083440A2 (en) * | 2004-02-19 | 2005-09-09 | Yale University | Identification of cancer protein biomarkers using proteomic techniques |
| AU2004322162B2 (en) * | 2004-08-13 | 2011-04-28 | Indivumed Gmbh | Use of transthyretin as a biomarker for colorectal adenoma; method for detection and test system |
| US20060105419A1 (en) * | 2004-08-16 | 2006-05-18 | Biosite, Inc. | Use of a glutathione peroxidase 1 as a marker in cardiovascular conditions |
| WO2006094149A2 (en) * | 2005-03-01 | 2006-09-08 | Exact Sciences Corporation | Methods and compositions for detecting adenoma |
| CN101283280A (en) * | 2005-08-18 | 2008-10-08 | Zadec私人有限公司 | Protein markers for diagnosing if colorectal cancer and use of said markers as drug targets for the treatment of said cance type |
| EP2177910A1 (en) * | 2005-11-10 | 2010-04-21 | Aurelium Biopharma Inc. | Tissue diagnostics for breast cancer |
| JP5715817B2 (en) * | 2007-07-19 | 2015-05-13 | ビオメリューＢｉｏｍｅｒｉｅｕｘ | Method for assay of liver fatty acid binding protein, CEA and CA19-9 for in vitro diagnosis of colorectal cancer |
| EP2195658A2 (en) * | 2007-09-28 | 2010-06-16 | Royal College of Surgeons in Ireland | A method of assessing colorectal cancer status in an individual |
| PL2223115T3 (en) * | 2007-12-10 | 2012-02-29 | Hoffmann La Roche | Seprase as a marker for cancer |
| EP2223116B1 (en) * | 2007-12-10 | 2014-11-19 | Roche Diagnostics GmbH | Marker panel for colorectal cancer |
| AU2009213671A1 (en) * | 2008-02-11 | 2009-08-20 | Hadasit Medical Research Services & Development Limited | Colon cancer associated transcript 1 (CCAT1) as a cancer marker |
| US20110076700A1 (en) * | 2008-02-29 | 2011-03-31 | Nihon University | Anti-crp antibody and utilization of the same |
| EP2255017A1 (en) * | 2008-03-18 | 2010-12-01 | Epigenomics AG | A method for optimizing and validating an assay for determining the presence or absence of a medical condition |
| WO2009138392A1 (en) * | 2008-05-14 | 2009-11-19 | ETH Zürich | Method for biomarker and drug-target discovery for prostate cancer diagnosis and treatment as well as biomarker assays determined therewith |
| EP2300829B1 (en) * | 2008-05-23 | 2014-07-23 | Pronota NV | New biomarker for diagnosis, prediction and/or prognosis of sepsis and uses thereof |
| EP2488659B1 (en) * | 2009-10-15 | 2019-12-11 | Crescendo Bioscience, Inc. | Biomarkers and methods for measuring and monitoring inflammatory disease activity |
| US10119959B2 (en) * | 2010-06-25 | 2018-11-06 | The Board Of Trustees Of The Leland Stanford Junior University | Method of assaying an individual for immune impairment |
| ES2545515T3 (en) * | 2011-01-28 | 2015-09-11 | F. Hoffmann-La Roche Ag | Combinatorial biomarkers for clinical applications in the management of lung cancer patients |
| JP2014507160A (en) * | 2011-02-22 | 2014-03-27 | カリス ライフ サイエンシズ ルクセンブルク ホールディングス エス．アー．エール．エル． | Circulating biomarker |
| EP2744919A4 (en) * | 2011-08-19 | 2015-04-08 | Myriad Genetics Inc | Gene signatures for lung cancer prognosis and therapy selection |
-
2013
- 2013-12-02 KR KR1020157017551A patent/KR20150090240A/en not_active Withdrawn
- 2013-12-02 CA CA2893158A patent/CA2893158A1/en not_active Abandoned
- 2013-12-02 EP EP13858410.7A patent/EP2926138A4/en not_active Ceased
- 2013-12-02 AU AU2013351947A patent/AU2013351947A1/en not_active Abandoned
- 2013-12-02 MX MX2015006757A patent/MX2015006757A/en unknown
- 2013-12-02 JP JP2015545504A patent/JP2016507723A/en active Pending
- 2013-12-02 CN CN201910577840.7A patent/CN110596385A/en active Pending
- 2013-12-02 BR BR112015012616A patent/BR112015012616A2/en not_active IP Right Cessation
- 2013-12-02 US US14/094,594 patent/US20140234854A1/en not_active Abandoned
- 2013-12-02 CN CN201380071930.XA patent/CN104969071B/en not_active Expired - Fee Related
- 2013-12-02 SG SG11201504241QA patent/SG11201504241QA/en unknown
- 2013-12-02 WO PCT/US2013/072691 patent/WO2014085826A2/en active Application Filing
-
2014
- 2014-10-28 US US14/526,221 patent/US20150111220A1/en not_active Abandoned
- 2014-10-28 US US14/526,282 patent/US20150111221A1/en not_active Abandoned
- 2014-10-28 US US14/526,181 patent/US20150111223A1/en not_active Abandoned
- 2014-10-28 US US14/526,265 patent/US20150111230A1/en not_active Abandoned
-
2017
- 2017-06-14 US US15/622,340 patent/US20170285033A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20140234854A1 (en) | 2014-08-21 |
| US20150111230A1 (en) | 2015-04-23 |
| CN110596385A (en) | 2019-12-20 |
| WO2014085826A2 (en) | 2014-06-05 |
| WO2014085826A3 (en) | 2014-10-23 |
| MX2015006757A (en) | 2015-11-30 |
| KR20150090240A (en) | 2015-08-05 |
| CA2893158A1 (en) | 2014-06-05 |
| EP2926138A2 (en) | 2015-10-07 |
| US20150111223A1 (en) | 2015-04-23 |
| AU2013351947A1 (en) | 2015-06-18 |
| EP2926138A4 (en) | 2016-09-14 |
| CN104969071B (en) | 2019-09-03 |
| JP2016507723A (en) | 2016-03-10 |
| US20170285033A1 (en) | 2017-10-05 |
| US20150111221A1 (en) | 2015-04-23 |
| BR112015012616A2 (en) | 2017-09-12 |
| CN104969071A (en) | 2015-10-07 |
| US20150111220A1 (en) | 2015-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201504241QA (en) | Method for evaluation of presence of or risk of colon tumors | |
| IL288181A (en) | Methods of treating cancer | |
| IL236181A0 (en) | Methods of detecting diseases or conditions | |
| GB2503627B (en) | Downhole apparatus | |
| LT2901341T (en) | Identification of tumor-protective epitopes for the treatment of cancers | |
| IL229889B (en) | Optical lesion assessment | |
| EP2911691A4 (en) | Methods of treating neuroendocrine tumors using wnt pathway-binding agents | |
| PT2876447T (en) | Method for detecting cancer | |
| IL237436A0 (en) | Method for screening cancer | |
| PT2876446T (en) | Method for detecting cancer | |
| EP2852403A4 (en) | Methods for modification of tissues | |
| GB2515417B (en) | Method for determining mineralogical composition | |
| EP2985605A4 (en) | Method for detecting colon cancer | |
| EP2909768A4 (en) | Evaluation of output-producing asset productivity | |
| PL2852323T3 (en) | Cumulative measurement of an analyte | |
| GB201215942D0 (en) | Method of treatent | |
| ZA201503833B (en) | Method of hemoglobin-f determination | |
| TWI560452B (en) | Probe card for circuit-testing | |
| GB201221046D0 (en) | Method of diagnosis | |
| GB201220082D0 (en) | Assessment of pancreatic cancer | |
| TWI560451B (en) | Probe card for circuit-testing | |
| AU2012900878A0 (en) | Method of assessing likelihood of cancer | |
| GB201200263D0 (en) | Detection of breast cancer | |
| GB201222952D0 (en) | Treatent of cancer | |
| GB201210764D0 (en) | Technique for measuring viscosity |